First Time Loading...
S

Shanghai OPM Biosciences Co Ltd
SSE:688293

Watchlist Manager
Shanghai OPM Biosciences Co Ltd
SSE:688293
Watchlist
Price: 37.55 CNY -3.82% Market Closed
Updated: May 11, 2024
Section:
 

Relative Value

The Relative Value of one Shanghai OPM Biosciences Co Ltd stock under the Base Case scenario is 46.76 CNY. Compared to the current market price of 37.55 CNY, Shanghai OPM Biosciences Co Ltd is Undervalued by 20%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
46.76 CNY
Undervaluation 20%
Relative Value
Price
S
Worst Case
Base Case
Best Case

Valuation Multiples

16
P/S
P/S
Price to Sales
16
vs History
81
vs Industry
37
Median 3Y
21.3
Median 5Y
21.3
Industry
8.2
Forward
15.4
More Details
47.9
P/E
P/E
Price to Earnings
47.9
vs History
77
vs Industry
4
Median 3Y
63.6
Median 5Y
63.6
Industry
27.4
Forward
63.2
More Details
41.7
P/OCF
P/OCF
Price to OCF
41.7
vs History
81
vs Industry
4
Median 3Y
57.3
Median 5Y
57.3
Industry
24.3
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-70.4
Median 5Y
-70.4
Industry
23
More Details
2
P/B
P/B
Price to Book Value
2
vs History
81
vs Industry
46
Median 3Y
2.8
Median 5Y
2.8
Industry
2.6
More Details
10.7
EV/S
EV/S
Enterprise Value to Sales
10.7
vs History
81
vs Industry
37
Median 3Y
15.9
Median 5Y
15.9
Industry
7.5
Forward
10.3
More Details
17.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
17.5
vs History
81
vs Industry
28
Median 3Y
26.1
Median 5Y
26.1
Industry
9.3
More Details
45.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
45.3
vs History
72
vs Industry
3
Median 3Y
65.2
Median 5Y
65.2
Industry
4.3
Forward
29.5
More Details
45.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
45.3
vs History
72
vs Industry
3
Median 3Y
65.2
Median 5Y
65.2
Industry
4.2
Forward
46.5
More Details
27.7
EV/OCF
EV/OCF
Enterprise Value to OCF
27.7
vs History
81
vs Industry
6
Median 3Y
43.8
Median 5Y
43.8
Industry
5.9
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-104.9
Median 5Y
-104.9
Industry
3.3
More Details
3.8
EV/IC
EV/IC
Enterprise Value to IC
3.8
vs History
81
vs Industry
38
Median 3Y
6.3
Median 5Y
6.3
Industry
4.9
More Details

Multiples Across Competitors

Competitors Multiples
Shanghai OPM Biosciences Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Shanghai OPM Biosciences Co Ltd
SSE:688293
4.3B CNY 16 47.9 45.3 45.3
US
Abbvie Inc
NYSE:ABBV
283.9B USD 5.2 58.9 12.8 19.5
US
Amgen Inc
NASDAQ:AMGN
166.4B USD 5.6 44.2 18.6 30.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
108.9B USD 11 30.1 24.2 25.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
107.6B USD 8.2 27.9 22.5 25
AU
CSL Ltd
ASX:CSL
134.9B AUD 6.3 36 21.8 27
US
Gilead Sciences Inc
NASDAQ:GILD
82.2B USD 3 169.8 6.8 8.9
US
Moderna Inc
NASDAQ:MRNA
44.9B USD 8.7 -7.5 -8.1 -7.2
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
32.4B USD 3.4 27.8 14.2 17.7
KR
Celltrion Inc
KRX:068270
40T KRW 18.4 74.6 45.6 62.9

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 136,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.